P/E at 61.23 vs Industry's 67.55: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Discount to Industry P/E

The current P/E of 61.23 for Apollo Hospitals Enterprise Ltd. stands approximately 9.3% below the hospital sector average of 67.55. This valuation gap suggests that the market is pricing the stock with a modest discount relative to its peers, despite its large-cap status and consistent earnings growth. Such a premium or discount often reflects investor sentiment about growth prospects, risk, and profitability. In this case, the discount may indicate cautious optimism, especially given the sector’s elevated valuation levels overall. Apollo Hospitals trades at a premium to many broader market stocks but remains attractively valued within its industry context — previously rated Strong Buy, what is Apollo Hospitals’ current rating?

Performance Across Timeframes: Consistent Outperformance

Examining returns across multiple periods reveals a consistent pattern of outperformance versus the Sensex. Over the past year, Apollo Hospitals has delivered a 13.15% gain, while the Sensex declined by 8.03%. Year-to-date, the stock’s 27.37% return starkly contrasts with the Sensex’s 12.12% loss, underscoring its resilience amid broader market volatility. Even in the shorter term, the stock has maintained positive momentum: a 5.69% rise over three months compared to the Sensex’s 1.22% advance, and a 2.12% gain over the past week against the Sensex’s 1.66% decline. This steady outperformance is further highlighted by a four-day consecutive gain streak, during which the stock rose 3.89%. The 0.11% gain on the most recent trading day also outpaced the hospital sector by 0.25%, signalling ongoing relative strength. Is this momentum sustainable or a temporary phase?

Moving Average Configuration: Bullish Technical Setup

The technical picture for Apollo Hospitals Enterprise Ltd. is notably constructive. The stock is trading above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages — a configuration that typically signals a strong uptrend and positive investor sentiment. This alignment suggests that the recent gains are supported by sustained buying interest rather than short-term speculation. Being just 3.54% below its 52-week high of ₹9,326.8 further confirms the stock’s proximity to peak levels seen over the past year. Such a technical setup often attracts momentum traders and can provide a foundation for continued price appreciation — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Sector Performance Context: Hospital Industry Trends

The hospital sector has experienced mixed results recently, with some companies reporting flat or negative returns amid cost pressures and regulatory challenges. However, Apollo Hospitals stands out as a large-cap leader with consistent positive returns. Its P/E ratio below the sector average suggests that the market may be factoring in some risks, but the stock’s superior performance relative to peers indicates operational strength. The sector’s average P/E of 67.55 is elevated, reflecting growth expectations, yet Apollo Hospitals manages to maintain a valuation discount while delivering strong returns. How does this valuation-performance tension affect investor decisions?

Rating Reassessment: Previously Strong Buy

MarketsMOJO had previously rated Apollo Hospitals Enterprise Ltd. as a Strong Buy. The rating was updated on 1 September 2026, reflecting a reassessment of the company’s fundamentals and market conditions. While the current rating is not disclosed, the data-driven approach considers valuation, performance, and technical factors comprehensively. The stock’s Mojo Score of 77.0 remains robust, supporting the view of sustained quality. Should investors in Apollo Hospitals hold, buy more, or reconsider?

Long-Term Performance: Exceptional Returns Over a Decade

Over the last 10 years, Apollo Hospitals has delivered a staggering 561.11% return, significantly outperforming the Sensex’s 160.05% gain over the same period. This long-term track record highlights the company’s ability to generate sustained growth and shareholder value. Even over five years, the stock’s 90.04% return dwarfs the Sensex’s 28.44%, reinforcing its status as a large-cap outperformer. Such historical performance underpins the valuation premium relative to the broader market, even if it trades at a discount within its sector. Does this justify the current valuation gap versus peers?

Market Capitalisation and Industry Standing

With a market capitalisation of approximately ₹1,28,974.84 crore, Apollo Hospitals Enterprise Ltd. is firmly established as a large-cap leader in the hospital sector. Its scale provides competitive advantages in terms of brand recognition, operational efficiencies, and access to capital. The stock’s proximity to its 52-week high, combined with its technical strength, suggests that investors continue to value its market position highly. The hospital industry remains competitive, but Apollo Hospitals has demonstrated resilience and adaptability through various market cycles.

Conclusion: A Balanced Valuation-Performance Profile

The data on Apollo Hospitals Enterprise Ltd. reveals a stock that balances a modest valuation discount against strong performance metrics and a bullish technical setup. Its P/E ratio below the sector average contrasts with its consistent outperformance across multiple timeframes, from short-term momentum to decade-long returns. The moving average configuration confirms a positive trend, while the sector context highlights the company’s relative strength amid mixed industry results. Previously rated Strong Buy, the recent rating reassessment reflects these nuanced factors — what is the current rating for Apollo Hospitals?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →